Resources

Client Alerts, News Articles, Blog Posts, & Multimedia

Everything you need to know about BMD and the industry.

El Contrato Escrito: La Herramienta Predilecta

Client Alert

No existe mejor herramienta a una disputa contractual que un documento firmado por las partes en el cual se expongan las obligaciones y acuerdos entre éstas.

Como regla general, los contratos orales son válidos a menos que una ley específica no los permita. Sin embargo, en práctica, un contrato oral es difícil de hacerlo cumplir y está lleno de un sinfín de circunstanciadas legales que complican la aplicabilidad de las supuestas obligaciones de las partes y restringe los remedios jurídicos que se puedan solicitar.

Si la persona o empresa con la cual se está haciendo una relación contractual no quiere poner lo que se acordó por escrito entonces hay que concluir que esta persona o empresa no tiene ningún interés o intención de cumplir con su aparte del acuerdo. Los contratos son como la póliza de seguros de carros, se tienen para quedar protegidos cuando suceda el incidente. Es importante que el contrato refleje todas las prestaciones, obligaciones y acuerdos entre las partes y exponga en blanco y negro las consecuencias de incumplir.

El contrato escrito es la herramienta predilecta para evitar largos litigios, costos legales excesivos y sirve como instrumento persuasivo a la parte que desea infringir la relación contractual a cumplir.

En BMD nos especializamos haciendo contratos. Contáctanos.


Multi-340B Contract Pharmacy Locations on the Brink? The Third Circuit’s Ruling Gives a Hint.

The 340B drug discount program requires pharmaceutical manufacturers to offer to sell their products at significant discounts to safety net providers called “covered entities.” In 1996, the Health Resources and Services Administration (HRSA) issued guidance authorizing covered entities to enter into a contract pharmacy arrangement with a single third-party contract pharmacy, to which the manufacturer would ship 340B medications but bill the covered entity. In 2010, HRSA issued revised guidance permitting covered entities to enter into an unlimited number of contract pharmacy arrangements.

Five Opportunities for Operations and Compliance Excellence in 2023

With the holidays behind us and the rest of the year ahead, now is the perfect time to get your operational/compliance house in order! Though your list might be a mile (or an inch) long, here are five places to start.

The Pregnant Workers Fairness Act - What Employers Need to Know

Effective June 27, 2023, the Pregnant Workers Fairness Act (PWFA) will require employers with at least 15 employees to provide reasonable accommodations for qualified employees with pregnancy-related restrictions unless doing so would impose an undue hardship on the employer.

Valley National Bank/Trulieve Loan: A Big Step Out of the Shadows

In a late December press release, Trulieve announced that it had secured a $71.5 million commercial bank loan. In addition to the amount of the loan, which may be the largest commercial bank loan to date to a cannabis company, the release prominently identified Valley Bank and featured both a quote from Valley’s Senior Vice President, John Myers, and a description of the Bank’s service platform and commitment to the cannabis industry.

The End of Non-Competes? The Impact It Will Have on the Healthcare Industry

On January 5, 2023, the Federal Trade Commission (“FTC”) announced a proposed rule that, if enacted, will ban employers from entering into non-compete clauses with workers (the “Rule”), and the Rule would void existing non-compete agreements. In their Notice, the FTC stated that if the Rule were to go into effect, they estimate the overall earnings of employees in the United States could increase by $250 billion to $296 billion per year. The Rule would also require employers to rescind non-competes that they had already entered into with their workers. For purposes of the Rule, the FTC has defined “worker” to also include any employees, interns, volunteers, and contractors.”